VAS, visual analogue scale

Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
B Mazières, N Scmidely, H J Hauselmann, E Martin-Mola, U Serni, A A Verbruggen, M Le Bars

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1158-1164; DOI: 10.1136/ard.2003.009431
Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36
O Svensson, M Malmenäs, L Fajutrao, E M Roos, L S Lohmander

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 781-784; DOI: 10.1136/ard.2005.040519
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study
T Dervieux, D Furst, D O Lein, R Capps, K Smith, J Caldwell, J Kremer

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1180-1185; DOI: 10.1136/ard.2004.033399
Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis
J Wolf, T Stranzl, M Filipits, G Pohl, R Pirker, B Leeb, J S Smolen

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 564-568; DOI: 10.1136/ard.2003.014985
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis
M A D’Agostino, P Conaghan, M Le Bars, G Baron, W Grassi, E Martin-Mola, R Wakefield, J-L Brasseur, A So, M Backhaus, M Malaise, G Burmester, N Schmidely, P Ravaud, M Dougados, P Emery

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1703-1709; DOI: 10.1136/ard.2005.037994
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid, M C Wick, J Lampa, S Lindblad, B Nordmark, L Klareskog, R F van Vollenhoven

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1744-1749; DOI: 10.1136/ard.2004.033571
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
J C van Denderen, M van der Paardt, M T Nurmohamed, Y M M A de Ryck, B A C Dijkmans, I E van der Horst-Bruinsma

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1761-1764; DOI: 10.1136/ard.2005.036491
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, L T H Jacobsson, R van Vollenhoven, N Feltelius, S Lindblad, L Klareskog

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 707-712; DOI: 10.1136/ard.2005.045872
Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial
G Kobelt, P Lindgren, A Singh, L Klareskog

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1174-1179; DOI: 10.1136/ard.2004.032789
Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis
M M J Nielen, A R van der Horst, D van Schaardenburg, I E van der Horst-Bruinsma, R J van de Stadt, L Aarden, B A C Dijkmans, D Hamann

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1199-1204; DOI: 10.1136/ard.2004.029389

Main menu

VAS, visual analogue scale

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

VAS, visual analogue scale

Pages